Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 3Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 5Colorectal Neoplasms 4Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Duodenal Neoplasms 2Colonic Polyps 2Colonic Neoplasms 2Small Size Gastrointestinal Stromal Tumors 1Rectal Neoplasms 1Predictive Cancer Model 1Precancerous Conditions 1Polyps 1Pathological Conditions, Anatomical 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1Neoplasms 1Locally Advanced Rectal Cancer (LARC) 1Intestinal Polyps 1Esophageal Squamous Cell Carcinoma 1Endoscopic Submucosal Dissection 1Barrett Esophagus 1Adenoma, Villous 1Adenoma 1

Interventions

Capecitabine 29Oxaliplatin 28Fluorouracil 16Radiotherapy 15Drug Therapy 11Leucovorin 10Bevacizumab 10Surgical Procedures, Operative 9Chemoradiotherapy 8Radiation 7sintilimab 6Consolidation Chemotherapy 6tislelizumab 5spartalizumab 5XELOX 5Specimen Handling 5Irinotecan 5Folfox protocol 5trifluridine tipiracil drug combination 4Neoadjuvant Therapy 4Endoscopy 4Cetuximab 4Biopsy 4toripalimab 3pembrolizumab 3irinotecan sucrosofate 3X-Rays 3Radiotherapy, Intensity-Modulated 3Proctectomy 3Mastectomy, Segmental 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Rectal Neoplasms × Endoscopic Mucosal Resection × Clear all
NCT06780787 2025-06-26

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

City of Hope Medical Center

Phase 2 Recruiting
26 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡